Overview

Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium

Status:
Unknown status

Trial end date:
2018-01-01

Target enrollment:

Participant gender:

Summary

Subjects with pterygium and associated dry eye symptoms (DES) are randomized into an active cohort (receiving ocular administration of Dipyridamole) or placebo cohort (ocular administration of vehicle). Monthly follow up is conducted for 12 months. Testing conducted at follow up will assess dry eye / pterygium symptoms and endpoints and review the efficacy of the intervention.

Phase:

Phase 2

Details

Lead Sponsor:

Ariel University

Treatments:

Dipyridamole